20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T19344 | Glycogen, Mussel | Glycogen | Endogenous Metabolite |
Glycogen, Mussel is a glycolytic intermediate and high-energy phosphate that ACTS as a form of energy storage for humans, animals, fungi and bacteria. | |||
T37577 | Glycogen Phosphorylase Inhibitor | ||
Glycogen phosphorylase in the liver, muscle, and brain initiate glycogenolysis by releasing glucose-1-phosphate from glycogen. Glycogen phosphorylase inhibitor is a cell-permeable acyl urea first identified as an inhibit... | |||
T40945 | Phospho-Glycogen Synthase Peptide-2(substrate) | ||
Phospho-Glycogen Synthase Peptide-2, a substrate for glycogen synthase kinase-3 (GSK-3), serves as a peptide substrate effective in the affinity purification of protein-serine kinases. | |||
T9987 | GSK3-IN-1 | GSK-3 | |
GSK3-IN-1 is a GSK3B-glycogen synthase kinase-3 beta inhibitor. | |||
T76380 | [Ala9,10, Lys11,12] Glycogen Synthase (1-12) | ||
[Glycogen Synthase (1-12) Ala9,10, Lys11,12] is a selective substrate for protein kinase C (PKC) phosphorylation. It serves to assess PKC activity [1]. | |||
T10202 | A 1070722 | GSK-3 | |
A 1070722 is a potent and selective GSK-3 inhibitor, with a Ki of 0.6 nM for both GSK-3α and GSK-3β. It can penetrate the blood-brain barrier (BBB) and accumulates in brain regions, thus potential for PET radiotracer for... | |||
T75808 | Phospho-Glycogen Synthase Peptide-2(substrate) TFA | ||
Phospho-Glycogen Synthase Peptide-2 (substrate) serves as a peptide substrate for glycogen synthase kinase-3 (GSK-3) and is utilized for the affinity purification of protein-serine kinases [1]. | |||
T3684 | CP21R7 | CP21 | GSK-3 , PKC |
CP21R7 (CP21) is an effective and specific GSK3β inhibitor. It is used as an activator of stem cells prior to the induction of differentiation of stem cells to smooth muscle and endothelial cells. CP21R7 can be combined ... | |||
T1965 | Bikinin | Abrasin | Others , GSK-3 |
Bikinin (Abrasin), a potent inhibitor of plant GSK-3/Shaggy-like kinase, activates BR signaling downstream of the BR receptor. | |||
T5956 | VP3.15 dihydrobromide | GSK-3 , PDE | |
VP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM , 0.88 μM,respectively.) | |||
T1957 | AZD2858 | GSK-3 | |
AZD2858 is a selective GSK-3 inhibitor, inhibiting tau phosphorylation at the S396 site and activating Wnt signaling pathway. | |||
T1755 | LY2090314 | GSK-3 | |
LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, a... | |||
T2166 | TWS119 | GSK-3 , Autophagy | |
TWS119 is a GSK-3β inhibitor; capable of inducing neuronal differentiation | |||
T1741 | AZD1080 | GSK-3 | |
AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor. | |||
T14066 | 9-ING-41 | Apoptosis , GSK-3 , Autophagy | |
9-ING-41 is a glycogen synthase kinase-3 inhibitor. | |||
T9611 | PF-04802367 | GSK-3 | |
PF-04802367 is a highly selective GSK-3 inhibitor with an IC50 of 2.1 nM based on a recombinant human GSK-3β enzyme assay and 1.1 nM based on ADP-Glo assay. It shows desirable central nervous system (CNS) properties and ... | |||
T3077 | SB 216763 | SB216763 | GSK-3 , Autophagy |
SB 216763 (SB216763) is an effective and specific GSK-3α/β inhibitor (IC50: 34.3 nM). | |||
T2261 | IM-12 | IM 12 | GSK-3 |
IM-12, an effective GSK-3β inhibitor(IC50=53 nM), regulates Wnt signalling. | |||
T10608 | BRD5648 | (R)-BRD0705 | GSK-3 |
BRD5648 ((R)-BRD0705) is an inactive (R)-enantiomer of BRD0705. BRD0705 is a GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM) and can be used in acute myeloid leukemia (AML) studies. | |||
T6358 | 1-Azakenpaullone | azakenpaullone | GSK-3 |
1-Azakenpaullone (azakenpaullone) is a potent and selective GSK-3β inhibitor with IC50 of 18 nM, >100-fold selectivity over CDK1/cyclin B and CDK5/p25. |